Long non-coding RNA (lncRNA) CYTOR promotes hepatocellular carcinoma proliferation by targeting the microRNA-125a-5p/LASP1 axis

References

• Ringelhan M, Pfister D, O’Connor T, et al. The immunology of hepatocellular carcinoma. Nat Immunol. 2018;19(Suppl):222–232.
   PubMedGoogle Scholar
• Wang Z, Wang MD, Zhen-Li LI, et al. Immunotherapy for hepatocellular carcinoma:research advances and clinical prospects. Acad J Second Military Med Univ. 2017;38(8):953–960.
   Google Scholar
• Chan A, Chan S, Chok K, et al. Treatment strategy for recurrent hepatocellular carcinoma: salvage transplantation, repeated resection or radiofrequency ablation? Liver Transpl. 2013;19(4):411–419.
   PubMed Web of Science ®Google Scholar
• Sadiq TS, Shrestha R, Weeks S, et al. Laparoscopic radiofrequency ablation provides local control of hepatocellular carcinoma in patients awaiting liver transplant. J Am Coll Surg. 2004;199(3–supp–S):16.
   Web of Science ®Google Scholar
• Gardini AC, Foschi FG, Conti F, et al. Immune inflammation indicators and ALBI score to predict occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals. Digest Liver Dis. 2018;50(1):50–51.
   Web of Science ®Google Scholar
• Young IC, Chuang ST, Gefen A, et al. A novel compressive stress-based osteoarthritis-like chondrocyte system. Exp Biol Med. 2017;242(10):1062–1071.
   Web of Science ®Google Scholar
• Chen W, Jia Y, Qi Z, et al. Downregulation of lncRNA OGFRP1 inhibits hepatocellular carcinoma progression by AKT/mTOR and Wnt/β-catenin signaling pathways. Cancer Manage Res. 2018;10:1817–1826.
   PubMed Web of Science ®Google Scholar
• Qi P, Wan-run L, Meng Z, et al. E2F1 induces LSINCT5 transcriptional activity and promotes gastric cancer progression by affecting the epithelial-mesenchymal transition. Cancer Manage Res. 2018;10:2563–2571.
   PubMed Web of Science ®Google Scholar
• Qian L, Huang J, Zhou N, et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 2013;41(9):9.
   Web of Science ®Google Scholar
• Huang X, Gao Y, Qin J, et al. LncRNA-MIAT promoted proliferation and invasion of HCC cells via sponging miR-214. American Journal of Physiology. Gastrointestinal and Liver Physiology. 2017;314(5):G559.
   PubMed Web of Science ®Google Scholar
• Sui J, Miao Y, Han J, et al. Systematic analyses of anovel lncRNA-associated signature as the prognostic biomarker for Hepatocellular Carcinoma . Cancer Medicine. 2018;7:3240–3256.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Lu C, Cui H. Long non-coding RNA SNHG22 facilitates hepatocellular carcinoma tumorigenesis and angiogenesis via DNA methylation of microRNA miR-16-5p. Bioengineered. 2021;12(1):7446–7458.
   PubMed Web of Science ®Google Scholar
• Feng Y, Wei G, Zhang L, et al. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis. Bioengineered. 2021;12(1):8217–8232.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Li K, Zou X, et al. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered. 2021;12(2):10862–10877.
   PubMed Web of Science ®Google Scholar
• Yue B, Liu C, Sun H, et al. A Positive Feed-Forward Loop between LncRNA-CYTOR and Wnt/β-Catenin Signaling Promotes Metastasis of Colon Cancer. Mol Ther. 2018;26(5):1287–1298.
   PubMed Web of Science ®Google Scholar
• Wang P, Jing L, Wei Z, et al. A Novel LncRNA-miRNA-mRNA Triple Network Identifies LncRNA RP11-363E7.4 as An Important Regulator of miRNA and Gene Expression in Gastric Cancer. Cell Physiol Biochem Int J Exp Cell Physiol Biochem Pharmacol. 2018;47:1025–1041.
   PubMedGoogle Scholar
• Alenka MI, Mojca T, Bti E, et al. Identifying Novel Glioma-Associated Noncoding RNAs by Their Expression Profiles. Int J Genomics. 2017;2017 :1–18.
   Web of Science ®Google Scholar
• Sun CC, Zhang L, Li G, et al. The lncRNA PDIA3P Interacts with miR-185-5p to Modulate Oral Squamous Cell Carcinoma Progression by Targeting Cyclin D2. Mol Ther Nucleic Acids. 2017;9:100–110.
   PubMedGoogle Scholar
• Vishnoi A, Rani S. MiRNA Biogenesis and Regulation of Diseases: an Overview. Methods in Molecular Biology (Clifton, N.J.). 2017;1509:1.
   PubMedGoogle Scholar
• Cao Q, Liu F, Ji K, et al. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression. J Exp Clin Cancer Res. 2017;36(1):29.
   PubMedGoogle Scholar
• Lai L, Chen J, Wang N, et al. MiRNA-30e mediated cardioprotection of ACE2 in rats with Doxorubicin-induced heart failure through inhibiting cardiomyocytes autophagy. Life Sciences. 2017;169:69.
   PubMed Web of Science ®Google Scholar
• Morishita A, Masaki T. mi RNA in hepatocellular carcinoma. Hepatol Res Off J Jap Soc Hepatol. 2015;45(2):128–141.
   PubMed Web of Science ®Google Scholar
• Kim JK, Noh JH, Jung KH, et al. Sirtuin7 oncogenic potential in human hepatocellular carcinoma and its regulation by the tumor suppressors MiR-125a-5p and MiR-125b. Hepatology. 2013;57(3):1055–1067.
   PubMed Web of Science ®Google Scholar
• Hsieh TH, Hsu CY, Tsai CF, et al. miR-125a-5p is a prognostic biomarker that targets HDAC4 to suppress breast tumorigenesis. Oncotarget. 2014;6(1):494.
   Google Scholar
• Jiang L, Huang Q, Chang J, et al. MicroRNA HSA-miR-125a-5p induces apoptosis by activating p53 in lung cancer cells. Exp Lung Res. 2011;37(7):387–398.
   PubMed Web of Science ®Google Scholar
• Chiyomaru T, Enokida H, Kawakami K, et al. Functional role of LASP1 in cell viability and its regulation by microRNAs in bladder cancer. Urol Oncol Sem Orig Invest. 2012;30(4):434–443.
   PubMed Web of Science ®Google Scholar
• Traenka C, Remke M, Korshunov A, et al. Role of LIM and SH3 Protein 1 (LASP1) in the Metastatic Dissemination of Medulloblastoma. Cancer Res. 2010;70(20):8003–8014.
   PubMed Web of Science ®Google Scholar
• Cao Y, Wang P, Ning S, et al. Identification of prognostic biomarkers in glioblastoma using a long non-coding RNA-mediated, competitive endogenous RNA network. Oncotarget. 2016;7(27):41737–41747.
   PubMed Web of Science ®Google Scholar
• Avram S, Coricovac DE, Pavel IZ, et al. Standardization of A375 human melanoma models on chicken embryo chorioallantoic membrane and Balb/c nude mice. Oncol Rep. 2017;38(1):89–99.
   PubMed Web of Science ®Google Scholar
• Toyokuni S, Kawaguchi W, Akatsuka S, et al. Intermittent microwave irradiation facilitates antigen-antibody reaction in Western blot analysis. Pathol Int. 2003;53(4):259–261.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. Advances in the management of hepatocellular carcinoma. Clinical Advances in Hematology & Oncology: H&O. 2017;15 Suppl 9(8):2–6.
   PubMed Web of Science ®Google Scholar
• Yu J, Xu QG, Wang ZG, et al. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma. J Hepatol. 2018;68(6):1214–1227.
   PubMed Web of Science ®Google Scholar
• Jiang T, Guan LY, Ye YS, et al. MiR-874 inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma by targeting SOX12. American Journal of Cancer Research. 2017;7(6):1310.
   PubMed Web of Science ®Google Scholar
• Zhou W, Wang Q, Xu Y, et al. RMP promotes epithelial-mesenchymal transition through NF-κB/CSN2/Snail pathway in hepatocellular carcinoma. Oncotarget. 2017;8(25):40373–40388.
   PubMedGoogle Scholar
• Lu M, Kong X, Wang H, et al. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis. Oncotarget. 2017;8(5):87955–87970.
   PubMedGoogle Scholar
• Liu L, C X, L E, et al. MicroRNA-18a promotes proliferation and metastasis in hepatocellular carcinoma via targeting KLF4. Oncotarget. 2017;8(40):68263.
   PubMedGoogle Scholar
• Geng C, Wang Z, Wang D, et al. LncRNADisease: a database for long-non-coding RNA-associated diseases. NAR. 2012;41:D983–D986.
   PubMed Web of Science ®Google Scholar
• Li H, Yu B, Li J, et al. Overexpression of lncRNA H19 enhances carcinogenesis and metastasis of gastric cancer. Oncotarget. 2014;5(8):2318–2329.
   PubMedGoogle Scholar
• Ye S, Yang L, Zhao X, et al. Bioinformatics method to predict two regulation mechanism: TF–miRNA–mRNA and lncRNA–miRNA–mRNA in pancreatic cancer. Cell Biochem Biophys. 2014;70(3):1849–1858.
   PubMed Web of Science ®Google Scholar
• Shi F, Xiao F, Ding P, et al. Long Noncoding RNA Highly Up-regulated in Liver Cancer Predicts Unfavorable Outcome and Regulates Metastasis by MMPs in Triple-negative Breast Cancer. Arch Med Res. 2016;47(6):446–453.
   PubMed Web of Science ®Google Scholar
• Ishii N, Ozaki K, Sato H, et al. Identification of a novel non-coding RNA, MIAT, that confers risk of myocardial infarction. J Hum Genet. 2006;51(12):1087–1099.
   PubMed Web of Science ®Google Scholar
• Zhu M, Chen Q, Liu X, et al. lncRNA H19/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J. 2014;281(16):3766–3775.
   PubMed Web of Science ®Google Scholar
• Taylor MA, Sossey-Alaoui K, Thompson CL, et al. TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Investig. 2012;123(1):150–163.
   Web of Science ®Google Scholar
• Xu T, Zhu Y, Wei QK, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29(11):2126–2131.
   PubMed Web of Science ®Google Scholar
• Li C, Pan S, Song Y, et al. Silence of lncRNA MIAT protects ATDC5 cells against lipopolysaccharides challenge via up-regulating miR-132. Artif Cells Nanomed Biotechnol. 2019;47(1):2521–2527.
   PubMed Web of Science ®Google Scholar
• Wang YL, Chen C, Wang XM. Effects of miR-339-5p on invasion and prognosis of hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology. 2016;40(1):51–56.
   PubMed Web of Science ®Google Scholar
• Xia Q, Wang Q, Lin F, et al. miR-125a-5p-abundant exosomes derived from mesenchymal stem cells suppress chondrocyte degeneration via targeting E2F2 in traumatic osteoarthritis. Bioengineered. 2021;12(2):11225–11238.
   PubMed Web of Science ®Google Scholar
• Wang RJ, Zheng YH, Wang P, et al. Serum miR-125a-5p, miR-145 and miR-146a as diagnostic biomarkers in non-small cell lung cancer. Int J Clin Exp Pathol. 2015;8(1):765–771.
   PubMed Web of Science ®Google Scholar
• Xu X, Tao Y, Niu Y, et al. miR-125a-5p inhibits tumorigenesis in hepatocellular carcinoma. Aging (Albany NY). 2019;11(18):7639–7662.
   PubMedGoogle Scholar
• Tazawa H, Tsuchiya N, Izumiya M, et al. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proceedings of the National Academy of Sciences of the United States of America. 2007;104(39):15472–15477.
   PubMed Web of Science ®Google Scholar
• Nishikawa R, Goto Y, Sakamoto S, et al. Tumor‐suppressive micro RNA‐218 inhibits cancer cell migration and invasion via targeting of LASP 1 in prostate cance. Cancer Sci. 2014;105(7):802–811.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Wang YY, Wei LI. Expression of Lasp1 protein in invasive breast cancer tissue and its significance in clinical prognosis. Mod Med J. 2016;44:519–522.
   Google Scholar
• Gao Q, Tang L, Wu L, et al. LASP1 promotes nasopharyngeal carcinoma progression through negatively regulation of the tumor suppressor PTEN. Cell Death Dis. 2018;9(3):393.
   PubMedGoogle Scholar